- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Trace Element Deficiency in South Africa
Total 6577 results
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMetastatic Hormone-sensitive Prostate CancerUnited States
-
Janssen Research & Development, LLCActive, not recruitingProstatic NeoplasmsUnited States, Italy, Czechia, Israel, Japan, Taiwan, Korea, Republic of, United Kingdom, France, Spain, Germany, Australia, Canada, Brazil, Russian Federation, Argentina, Netherlands, Poland
-
BayerActive, not recruitingNon-diabetic Chronic Kidney DiseaseHong Kong, United States, Spain, China, Belgium, Taiwan, Australia, Korea, Republic of, Russian Federation, United Kingdom, Singapore, Malaysia, Japan, Greece, Israel, Hungary, Italy, Czechia, Denmark, Argentina, Bulgaria, Mexico, I... and more
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic NeoplasmsUnited States, Australia, France, Poland, United Kingdom, Germany, Taiwan, Spain, Belgium, Israel, Romania, Japan, Canada, Denmark, Finland, Korea, Republic of, Netherlands, New Zealand, Russian Federation, Hungary, Austria, Sweden, Slovaki... and more
-
Loxo Oncology, Inc.Eli Lilly and CompanyAvailableBreast Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Other Solid Tumors With Evidence of Activating RET AlterationSpain, United States, Australia, France, Germany, Israel, Italy, Japan, New Zealand, Poland, Singapore, Switzerland
-
Vertex Pharmaceuticals IncorporatedRecruitingProteinuric Kidney DiseaseUnited States, Spain, Ghana, France, United Kingdom, Belgium, Brazil, Colombia, Portugal, Canada, Puerto Rico, Netherlands
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingEndometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Recurrent Uterine Corpus Cancer | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus Cancer AJCC v7 | Stage IIIC Uterine Corpus Cancer AJCC v7 | Stage IVA Uterine Corpus Cancer... and other conditionsUnited States
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Renal Insufficiency | Ischemic Stroke | Anemia | Thrombocytopenia | Coagulation Disorder | Hemorrhagic Stroke | Bleeding Disorder | Hematological DiseasesUnited States, Hong Kong, Canada, China, Spain, Belgium, Germany, Portugal, Switzerland, Taiwan, United Kingdom, Austria, Italy, Netherlands, Singapore
-
Boehringer IngelheimCompletedChronic Kidney DiseaseSpain, Canada, Australia, United States, Japan, Malaysia, United Kingdom, China, Mexico, Denmark, Russian Federation, Germany, Portugal, Hong Kong, Poland, Argentina, New Zealand, Sweden
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingAtezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder CancerRecurrent Bladder Urothelial Carcinoma | Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage I Bladder Urothelial Carcinoma AJCC v6 and v7United States, Canada
-
AstraZenecaCompletedDiabetic Kidney DiseaseUnited States, Chile, Korea, Republic of, Japan, Argentina, Canada, Peru
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellSpain, United States, Australia, Canada, Chile, Colombia, France, Hungary, Israel, Korea, Republic of, Netherlands, New Zealand, Poland, United Kingdom
-
Cara Therapeutics, Inc.TerminatedChronic Kidney Diseases | PruritusUnited States
-
National Cancer Institute (NCI)Children's Oncology GroupRecruitingMalignant Solid Neoplasm | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Ependymoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Glioma | Recurrent Malignant Solid Neoplasm | Recurrent... and other conditionsUnited States, Puerto Rico, Australia
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingCervical CancerUnited States, Korea, Republic of, Hong Kong, Canada
-
Merck Sharp & Dohme LLCGOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingEndometrial NeoplasmsAustralia, United States, Germany, Israel, Korea, Republic of, Poland, Turkey, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, Finland, Hungary, Ireland, Italy, Japan, Netherlands, New Zealand, Norway, Russian Federation, Spain, Swed... and more
-
AmgenTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Austria, Belgium, Italy, Netherlands, Spain, Canada, Denmark, Germany, Korea, Republic of, Russian Federation, Hong Kong, Greece, Japan
-
ExelixisTakeda; Roche-GenentechActive, not recruitingMetastatic Prostate Cancer | Prostate AdenocarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Russian Federation, Singapore, Spain, ... and more
-
Sumitomo Pharma Switzerland GmbHRecruitingEndometriosis | Uterine FibroidsUnited States
-
National Cancer Institute (NCI)Active, not recruitingLung Adenocarcinoma | Lung Large Cell Carcinoma | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Minimally Invasive Lung Adenocarcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC v7 | Lung Squamous Cell Carcinoma | Lung Adenocarcinoma, Mixed SubtypeUnited States
-
Eli Lilly and CompanyRecruitingOverweight and ObesityUnited States, Australia, Italy, Hungary, Netherlands, Canada, France, Spain, United Kingdom, Germany, Argentina, Czechia, Israel, Austria, Belgium, Greece, Turkey, Mexico, Romania, Brazil, India, Slovakia, Poland, Puerto Rico, Denmark
-
AstraZenecaCompletedChronic Kidney DiseaseUnited States, Canada, Spain, United Kingdom, Denmark, Germany, Korea, Republic of, Brazil, Hungary, Mexico, Peru, Philippines, Vietnam, China, Japan, Argentina, Ukraine, Poland, Russian Federation, India, Sweden
-
Regeneron PharmaceuticalsRecruitingRecurrent Endometrial Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer | Recurrent Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Italy, United Kingdom, Netherlands, Belgium, Australia, France, Israel
-
Sanofi Pasteur, a Sanofi CompanyCompletedPertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Pneumococcal Immunisation | Hepatitis B Immunisation | Haemophilus Influenzae Type b Immunisation | Polio Immunisation | Measles Immunisation | Rubella Immunisation | Varicella Immunisation | Mumps ImmunisationUnited States, Canada, Honduras, Puerto Rico
-
AmgenCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States, France, Italy, Spain, United Kingdom, Belgium, Canada, Poland, Switzerland, Korea, Republic of, Russian Federation, Hong Kong, Portugal, South Africa, Israel, Romania, Bulgaria, Greece, Australia, Sweden, Japan, Latvia and more
-
AbbVieCompletedUterine Fibroids | Heavy Menstrual BleedingUnited States, Canada
-
ObsEva SACompletedUterine Fibroids | Heavy Menstrual BleedingUnited States
-
AbbVieCompletedUterine Fibroids | Heavy Menstrual BleedingUnited States, Canada, Puerto Rico
-
GlaxoSmithKlineCompletedNeoplasms, ProstateFrance, Germany, Spain, United States, Netherlands, Canada, United Kingdom, Finland, Chile, Sweden, Argentina, Greece
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Italy, Spain, Belgium, Canada, France, Korea, Republic of, United Kingdom, Brazil, Czechia, Turkey, Australia, Chile, Germany, Japan, Netherlands, Slovakia
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedTesticular Germ Cell Tumor | Extragonadal Germ Cell TumorUnited States, Canada
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Renal Cell CarcinomaUnited States, Peru
-
Astellas Pharma Global Development, Inc.Seagen Inc.Active, not recruitingBladder Cancer | Urothelial Cancer | Ureteral CancerUnited States, Japan, Korea, Republic of, Taiwan, Argentina, Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Portugal, Russian Federation, Spain, Switzerland, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Squamous Cell, Non-small-cell LungPoland, Korea, Republic of, United States, Argentina, Australia, Austria, Brazil, Canada, France, Germany, Japan, Mexico, New Zealand, Romania, Russian Federation, Spain, Taiwan, Turkey, Ukraine, United Kingdom
-
BayerCompletedProstatic NeoplasmsBelgium, Spain, Canada, France, Switzerland, Germany, United Kingdom, Denmark, Russian Federation, Sweden, Israel, Italy, Netherlands, Norway, Czech Republic, Finland, Poland, Ireland, Mexico
-
Bristol-Myers SquibbTerminatedLupus NephritisAustralia, China, Italy, Taiwan, Turkey, United States, Hong Kong, Spain, Russian Federation, Korea, Republic of, Japan, Israel, Romania, Puerto Rico, Argentina, Brazil, Canada, Chile, Colombia, Czechia, India, Mexico, Peru
-
National Cancer Institute (NCI)Active, not recruitingBladder Urothelial Carcinoma | Stage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8United States
-
GlaxoSmithKlineCompletedAnaemiaUnited States, Canada, France, Russian Federation, Spain, Australia, United Kingdom, Romania, Brazil, Korea, Republic of, Italy, Poland, Argentina, Mexico
-
Oxford BioMedicaSanofiCompletedClear Cell Renal CarcinomaUnited States, Spain, Israel, United Kingdom, France, Russian Federation, Germany, Poland, Romania, Ukraine
-
Janssen Research & Development, LLCRecruitingUrinary Bladder NeoplasmsUnited States, Korea, Republic of, France, Israel, Spain, Italy, United Kingdom, Belgium, Netherlands, Germany
-
Pathalys PharmaLaunch TherapeuticsRecruitingSecondary Hyperparathyroidism | End-stage Kidney Disease (ESKD)United States, Bulgaria, Spain, Portugal, Poland, Serbia
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellPoland, Australia, Japan, United States, Korea, Republic of, Taiwan, China, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Malaysia, Mexico, Netherlands, New Zealand, Romani... and more
-
AbbVieRecruiting
-
ShireCompletedHyperphosphatemiaUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Ovarian Carcinoma | Ovarian Clear Cell AdenocarcinomaUnited States, Korea, Republic of
-
NRG OncologyNational Cancer Institute (NCI)CompletedFallopian Tube Carcinoma | Endometrial Serous Adenocarcinoma | Ovarian Carcinoma | Malignant Female Reproductive System Neoplasm | Primary Peritoneal Carcinoma | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus Cancer AJCC v7 | Stage IIIC Uterine Corpus Cancer AJCC v7 | Stage IVA... and other conditionsUnited States, Canada
-
pharmaand GmbHFoundation MedicineActive, not recruitingMetastatic Castration Resistant Prostate CancerUnited States, Canada, Spain, France, Australia, Ireland, Belgium, Denmark, United Kingdom, Germany, Israel, Italy
-
zr Pharma & GmbHFoundation MedicineCompletedMetastatic Castration Resistant Prostate CancerUnited States, Spain, United Kingdom, France, Australia, Belgium, Denmark, Israel, Germany, Ireland, Canada, Italy